One-Year Outcomes of Laparoscopic Adjustable Gastric Banding Based on Bariatric Analysis and Reporting Outcome System (BAROS) in Morbidly Obese Korean Patients

PURPOSE: This study aimed to compare amount of weight loss, serum laboratory results, and bariatric analysis and reporting outcome system (BAROS) scores obtained before surgery with those obtained 1 year after laparoscopic adjustable gastric banding (AGB). MATERIALS AND METHODS: From January 2013 to November 2014, 32 consecutive patients who underwent AGB were enrolled in this study. This study was a retrospective analysis of our prospectively collected database. The BAROS score included BAROS weight, medical condition, quality of life, and complications recorded 1 year after AGB. Demographic and post-operative data were also collected and analyzed. RESULTS: Thirty-two patients were enrolled in this study, comprising 26 women and 6 men, with an average body mass index of 39.0±6.1 kg/m². The total BAROS score 1 year post AGB was 4.6±1.7, and it was classified as excellent grade. Among them, the quality of life score was 1.8±0.6. Four minor complications were noted. The serum laboratory values improved 1 year post surgery, including hemoglobin A1c, c-peptide, insulin, Homeostatic model assessment of estimated insulin resistance (HOMA IR), Homeostatic model assessment of beta-cell function (HOMA B), triglyceride, total protein, and uric acid. CONCLUSION: AGB showed that it is acceptable in aspect of BAROS outcome as well as weight loss, and serum laboratory result in short-term period.

Evaluación de la calidad de vida post cirugía bariátrica mediante la aplicación del score de baros en el Hospital General Enrique Garcés - Quito. enero ­ marzo 2013 / Evaluation of the quality of life post bariatric surgery through the application of the score of baros in the Hospital General Enrique Garcés - Quito. january-march 2013

Se presenta un estudio retrospectivo de carácter descriptivo, de 100 pacientes opera-dos por obesidad con diferentes técnicas en el Hospital Enrique Garcés de la ciudad de Quito, el cual nos muestra la tendencia actual al predominio del Bypass Gástrico y Gastrectomía vertical en manga, a quienes durante el seguimiento, se les aplicó el SCORE DE BAROS, evidenciando una mejoría integral de la calidad de vida que complementa a la disminución del peso y resolución de las comorbilidades en los pacientes. Resultados: El 86% corresponde a mujeres y el 14% a varones, con una media de IMC de 36; hubo hasta un 95,4% de mejoría en la calidad de vida luego de aplicado el test de Oria Moorehead que se enfoca en aspectos de relaciones humanas, trabajo y vida sexual. Las comorbilidades mejoraron en hasta un 53%

A retrospective descriptive study of 100 pa-tients operated by obesity with different te-chniques in the Enrique Garcés Hospital of the City of Quito, which shows the actual trend of the prevalence of gastric bypass and vertical sleeve gastrectomy, to which during monitoring were applied the SCO-RE OF BAROS evidencing a comprehensive improvement in the quality of life that com-plements weight reduction and resolution of comorbidities in patients.Results: 86% female 14% male, with a mean BMI of 36, there were a 95.4% of improve-ment in the quality of life after applying the test of Oria Moorehead that focuses on as-pects of human relationships, work and se-xual life. Comorbidities improved in a 53%.

Validation of the Korean version Moorehead-Ardelt quality of life questionnaire II

PURPOSE: To investigate the weight loss effects with higher sensitivity, disease specific quality of life (QoL) instruments were important. The Moorehead-Ardelt quality of life questionnaire II (MA-II) is widely used, because it was simple and validated the several languages. The aims of present study was performed the translation of MA-II Korean version and the validation compared with EuroQol-5 dimension (EQ-5D), obesity-related problems scale (OP-scale), and impact of weight quality of life-lite (IWQoL-Lite). METHODS: The study design was a multicenter, cross-sectional survey and this study was included the postoperative patients. The validation procedure is translation-back translation procedure, pilot study, and field study. The instruments of measuring QoL included the MA-II, EQ-5D, OP-scale, and IWQoL-lite. The reliability was checked through internal consistency using Cronbach alpha coefficients. The construct validity was assessed the Spearman rank correlation between 6 domains of MA-II and EQ-5D, OP-scale, and 5 domains of IWQoL-Lite. RESULTS: The Cronbach alpha of MA-II was 0.763, so the internal consistency was confirmed. The total score of MA-II was significantly correlated with all other instruments; EQ-5D, OP-scale, and IWQoL-Lite. IWQoL-lite (rho = 0.623, P < 0.001) was showed the strongest correlation compared with MA-II, followed by OP-scale (rho = 0.588, P < 0.001) and EQ-5D (rho = 0.378, P < 0.01). CONCLUSION: The Korean version MA-II was valid instrument of measuring the obesity-specific QoL. Through the present study, the MA-II was confirmed to have good reliability and validity and it was also answered simple for investigating. Thus, MA-II could be estimated sensitive and exact QoL in obesity patients.